Reuters logo
BRIEF-J&J says U.S. FDA expands indication of Invokamet
May 24, 2016 / 12:21 PM / a year ago

BRIEF-J&J says U.S. FDA expands indication of Invokamet

May 24 (Reuters) - Johnson & Johnson :

* U.S. FDA expands indication of Invokamet to include first-line treatment of adults with type 2 diabetes Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below